Case Series: Cariprazine in Early-Onset Schizophrenia | April 2023

Articles

Frontiers in Psychiatry

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1155518/full

Broad Efficacy of Cariprazine on Depressive Symptoms in Bipolar Disorder and the Clinical Implications | September 2020

Articles

Primary Care Companion for CNS Disorders

https://doi.org/10.4088/PCC.20m02611

Long-Term Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder | March 2019

Articles

International Clinical Psychopharmacology

https://journals.lww.com/intclinpsychopharm/fulltext/2019/03000/Long_term_safety_and_tolerability_of_cariprazine.4.aspx

Early-Onset Schizophrenia with Predominantly Negative Symptoms: A Case Study of a Drug-Naive Female Patient Treated with Cariprazine | April 2020

Articles

Frontiers in Pharmacology

https://www.frontiersin.org/articles/10.3389/fphar.2020.00477/full

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies | April 2021

Articles

Neuropsychiatric Disease and Treatment

https://doi.org/10.2147/NDT.S301225

Efficacy of Cariprazine in Bipolar I Depression Across Patient Characteristics: A Post Hoc Analysis of Pooled Randomized, Placebo-Controlled Studies | March 2021

Articles

International Clinical Psychopharmacology

https://doi.org/10.1097/YIC.0000000000000344

Antidepressant Efficacy of Cariprazine in Bipolar Disorder and the Role of Its Pharmacodynamic Properties: A Hypothesis Based on Data | April 2023

Articles

European Neuropsychopharmacology

https://www.sciencedirect.com/science/article/pii/S0924977X23000524

Brexpiprazole and Cariprazine: Distinguishing Two New Atypical Antipsychotics from the Original Dopamine Stabilizer Aripiprazole | October 2016

Articles

NCBI>Therapeutic Advances in Psychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228714/

Preferential Binding to Dopamine D3 Over D2 Receptors by Cariprazine in Patients with Schizophrenia Using PET with the D3/D2 Receptor Ligand [(11)C]-(+)-PHNO | August 2016

Articles

Psychopharmacology

https://link.springer.com/article/10.1007/s00213-016-4382-y

Cariprazine: Patients with Treatment-Resistant Schizophrenia | July 2021

Articles

Neuropsychiatric Disease and Treatment

https://doi.org/10.2147/NDT.S315653

Cariprazine, the New Broad Spectrum Antipsychotic: Clinical Data of Schizophrenia, Bipolar Mania, Bipolar Depression and Major Depression Studies (Meetings-Events) | October 2018

Multimedia (Lectures-Conferences)

European College of Neuropsychopharmacology

http://www.ecnp.eu/presentations/CG18/S.08.05/default.aspx

Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience | February 2021

Articles

Neuropsychiatric Disease and Treatment

https://doi.org/10.2147/NDT.S298005

Cariprazine versus Risperidone Monotherapy for Treatment of Predominant Negative Symptoms in Patients with Schizophrenia: A Randomised, Double-Blind, Controlled Trial | February 2017

Abstracts

Lancet

https://doi.org/10.1016/S0140-6736(17)30060-0

Cariprazine as a Treatment Across the Bipolar I Spectrum from Depression to Mania: Mechanism of Action and Review of Clinical Data | February 2020

Articles

Therapeutic Advances in Psychopharmacology

https://journals.sagepub.com/doi/10.1177/2045125320905752

Cariprazine Tackles Negative Psychosis Symptoms (Meetings-Events) | June 2017

Abstracts (Summaries)

Medscape>American Society of Clinical Psychopharmacology

https://www.medscape.com/viewarticle/881812

Relationship between the Timing of Relapse and Plasma Drug Levels Following Discontinuation of Cariprazine Treatment in Patients with Schizophrenia: Indirect Comparison with Other Second-Generation Antipsychotics After Treatment Discontinuation | August 2019

Articles

Neuropsychiatric Disease and Treatment

https://www.dovepress.com/relationship-between-the-timing-of-relapse-and-plasma-drug-levels-foll-peer-reviewed-article-NDT

Cariprazine Add-On in Inadequate Clozapine Response: A Report on Two Cases | February 2021

Articles

Clinical Psychopharmacology and Neuroscience

http://www.cpn.or.kr/journal/view.html?doi=10.9758/cpn.2021.19.1.174

Successful High Dose Antipsychotic Treatment with Cariprazine in Patients on the Schizophrenia Spectrum: Real-World Evidence from a Spanish Hospital Setting | February 2023

Articles

Frontiers in Psychiatry

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1112697/full

Dosing Cariprazine within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia | January 2022

Articles

Frontiers in Psychiatry

https://www.frontiersin.org/articles/10.3389/fpsyt.2021.770234/full

Add-On Cariprazine in Patients with Long-Term Clozapine Treatment and Treatment Resistant Schizophrenia: Two Cases of Psychotic Deterioration and Pisa Syndrome | May 2022

Articles

Clinical Psychopharmacology and Neuroscience

https://www.cpn.or.kr/journal/view.html?doi=10.9758/cpn.2022.20.2.398

Effects of Cariprazine on Cognition in Patients with Bipolar Mania or Mixed States: Post Hoc Analysis from 3 Randomized, Controlled Phase III Studies | May 2021

Abstracts

CNS Spectrums

https://doi.org/10.1017/s1092852921000213

Cariprazine in Offender Patient with Acute Psychosis and Aggressive Behavior: Case Report | December 2022

Articles

Psychiatry Research Case Reports

https://www.sciencedirect.com/science/article/pii/S2773021222000864

Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials | August 2016

Abstracts

CNS Drugs

https://link.springer.com/article/10.1007/s40263-016-0382-z

The Efficacy of Cariprazine in Negative Symptoms of Schizophrenia: Post Hoc Analyses of PANSS Individual Items and PANSS-Derived Factors | February 2019

Articles

European Psychiatry

https://www.sciencedirect.com/science/article/pii/S092493381930015X

Cariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials | December 2021

Articles

Frontiers in Psychiatry

https://www.frontiersin.org/articles/10.3389/fpsyt.2021.769897/full

Evaluation of the Long-Term Safety and Tolerability of Cariprazine in Patients with Schizophrenia: Results from a 1-Year Open-Label Study | May 2017

Articles

CNS Spectrums

https://doi.org/10.1017/S1092852917000220

Case Report: Treatment-Resistant Schizophrenia with Auto-Aggressive Compulsive Behavior-Successful Management with Cariprazine | June 2023

Articles

Frontiers in Psychiatry

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1209077/full

Efficacy of Adjunctive Low-Dose Cariprazine in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial | November 2018

Articles

International Clinical Psychopharmacology

https://journals.lww.com/intclinpsychopharm/Fulltext/2018/11000/Efficacy_of_adjunctive_low_dose_cariprazine_in.3.aspx

Population Pharmacokinetics of Cariprazine and Its Major Metabolites | November 2020

Articles

European Journal of Drug Metabolism and Pharmacokinetics

https://link.springer.com/article/10.1007/s13318-020-00650-4

Relationship Between Plasma Concentrations and Clinical Effects of Cariprazine in Patients with Schizophrenia or Bipolar Mania | October 2019

Articles

Clinical and Translational Science

https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1111/cts.12720

Global Improvement with Cariprazine in the Treatment of Bipolar I Disorder and Schizophrenia: A Pooled Post Hoc Analysis | November 2017

Articles

International Journal of Clinical Practice

https://onlinelibrary.wiley.com/doi/full/10.1111/ijcp.13037

Cariprazine for the Treatment of Bipolar Mania with Mixed Features: A Post Hoc Pooled Analysis of 3 Trials | July 2019

Articles

Journal of Affective Disorders

https://www.sciencedirect.com/science/article/pii/S0165032718322092

Tolerability of Cariprazine in the Treatment of Acute Bipolar I Mania: A Pooled Post Hoc Analysis of 3 Phase II/III Studies | March 2017

Articles

Journal of Affective Disorders

https://www.sciencedirect.com/science/article/pii/S0165032716321632

Cariprazine in the Treatment of Acute Mania in Bipolar I Disorder: A Double-Blind, Placebo-Controlled, Phase III Trial | November 2014

Articles

Journal of Affective Disorders

https://www.sciencedirect.com/science/article/pii/S0165032714007289

Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study | March 2019

Articles

American Journal of Psychiatry

https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2018.18070824

An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients with Bipolar I Depression | November 2015

Articles

American Journal of Psychiatry

https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2015.15020164

Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients with Predominantly Negative Symptoms (Open-Label, Non-Controlled Study) | January 2022

Articles

Frontiers in Psychiatry

https://www.frontiersin.org/articles/10.3389/fpsyt.2021.770592/full

Long-Term Cariprazine Treatment for the Prevention of Relapse in Patients with Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial | July 2016

Articles

Schizophrenia Research

https://www.sciencedirect.com/science/article/pii/S0920996416303127

Cariprazine for Bipolar Depression: What Is the Number Needed to Treat, Number Needed to Harm and Likelihood to Be Helped or Harmed? | July 2019

Abstracts

International Journal of Clinical Practice

https://onlinelibrary.wiley.com/doi/10.1111/ijcp.13397

Efficacy and Safety of Cariprazine in Acute Management of Psychiatric Disorders: A Meta-Analysis of Randomized Controlled Trials | March 2020

Articles

NCBI>Psychiatria Danubina

https://pubmed.ncbi.nlm.nih.gov/32303028/

Effect of Cariprazine Across the Symptoms of Mania in Bipolar I Disorder: Analyses of Pooled Data from Phase II/III Trials | September 2015

Articles

European Neuropsychopharmacology

https://www.sciencedirect.com/science/article/pii/S0924977X1500276X

Efficacy of Cariprazine on Negative Symptoms in Patients with Acute Schizophrenia: A Post Hoc Analysis of Pooled Data | August 2018

Articles

Schizophrenia Research

https://www.sciencedirect.com/science/article/pii/S0920996418305127

Efficacy and Safety of Cariprazine in Bipolar I Depression: A Double-Blind, Placebo-Controlled Phase 3 Study | October 2019

Articles

Bipolar Disorders

https://onlinelibrary.wiley.com/doi/10.1111/bdi.12852

New Developments in the Management of Schizophrenia and Bipolar Disorder: Potential Use of Cariprazine | November 2015

Articles

Therapeutics and Clinical Risk Management

https://www.dovepress.com/new-developments-in-the-management-of-schizophrenia-and-bipolar-disord-peer-reviewed-article-TCRM

Case Report: Cariprazine in a Patient with Schizophrenia, Substance Abuse, and Cognitive Dysfunction | August 2021

Articles

Frontiers in Psychiatry

https://www.frontiersin.org/articles/10.3389/fpsyt.2021.727666/full

Clinically Relevant Response and Remission Outcomes in Cariprazine-Treated Patients with Bipolar I Disorder | September 2017

Articles

Journal of Affective Disorders

https://www.sciencedirect.com/science/article/pii/S0165032717304901

Efficacy and Acceptability of Cariprazine in Acute Exacerbation of Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials | February 2018

Abstracts

Journal of Clinical Psychopharmacology

https://doi.org/10.1097/jcp.0000000000000834

Healthcare Resource Utilization, Costs and Treatment Patterns in Patients with Bipolar Disorder Treated with Lurasidone or Cariprazine | February 2021

Articles

Journal of Medical Economics

https://www.tandfonline.com/doi/full/10.1080/13696998.2021.1890428

Cariprazine and Akathisia, Restlessness, and Extrapyramidal Symptoms in Patients with Bipolar Depression | March 2021

Articles

Journal of Affective Disorders

https://doi.org/10.1016/j.jad.2021.03.076

The Efficacy of Cariprazine on Function in Patients with Bipolar Depression: A Post Hoc Analysis of a Randomized Controlled Trial | June 2021

Articles

Current Medical Research and Opinion

https://www.tandfonline.com/doi/full/10.1080/03007995.2021.1932446